AVIYA helps early stage biopharmaceutical and device firms by providing upfront strategic planning and feasibility assessments, clinical trial development and operational services, regulatory and medical report writing services and licensing evaluation services.

Countless scientific and business challenges must be met to turn the discovery of a new therapeutic or important device into a clinical candidate with real medical and market potential.

Early stage development companies must balance scientific, clinical and regulatory requirements with business, financial and funding resources when devising their development plans.

The development approach must rigorously explore all viable development paths, and ensure that the development strategy clearly establishes the compound’s potential in filling medical need as soon as possible.

It is essential to minimize risk by adeptly managing the uncertainties that are part of early stage drug development, and by having an in-depth knowledge of the therapeutic area and executing programs that will meet critical endpoints and milestones within budget and on time.